SIMULPHARMA ApS — Credit Rating and Financial Key Figures

CVR number: 32832075
Marievej 24, 2950 Vedbæk
gulli@simulpharma.com
tel: 51828267

Income statement (kDKK)

20192020202120222023
Fiscal period length1212121212
Net sales905.00719.00636.00484.00114.98
External services- 105.00-78.00
Gross profit905.00719.00636.00406.00114.98
Costs of management- 633.00- 590.00- 615.00- 464.00- 172.32
Costs of distribution- 287.00-86.00
EBIT-15.0043.00-84.00-58.00-57.34
Other financial expenses-1.00
Pre-tax profit-15.0043.00-85.00-58.00-57.34
Income taxes2.00-6.002.00
Net earnings-13.0037.00-83.00-58.00-57.34

Assets (kDKK)

20192020202120222023
Intangible assets total
Tangible assets total
Investments total
Long term receivables total
Inventories total
Current trade debtors71.00
Prepayments and accrued income6.0011.00
Current other receivables4.00
Current deferred tax assets13.00
Short term receivables total90.0015.00
Cash and bank deposits121.00230.00138.0090.0022.48
Cash and cash equivalents121.00230.00138.0090.0022.48
Balance sheet total (assets)211.00245.00138.0090.0022.48

Equity and liabilities (kDKK)

20192020202120222023
Share capital80.0080.0080.0080.0080.00
Retained earnings118.00105.00141.0058.00-0.18
Profit of the financial year-13.0037.00-83.00-58.00-57.34
Shareholders equity total185.00222.00138.0080.0022.48
Non-current liabilities total
Current loans from credit institutions26.00
Short-term deferred tax liabilities6.00
Accruals and deferred income17.0010.00
Current liabilities total26.0023.0010.00
Balance sheet total (liabilities)211.00245.00138.0090.0022.48
Try the full version of our system for free
Bankruptcy risk visualization example

... and more!

No registration needed.